Latest Security News

DMC Mining's progress in Guinea is stalled as the government halts new exploration licences until after the December presidential election, prompting a 12-month extension on acquisition terms.

Cluey Ltd has formalised its acquisition of Education Futures Group, the parent of Art of Smart, in a deal valued up to $6.5 million combining cash and shares. Completion is expected by January 2026, contingent on conditions and an ongoing entitlement offer.

FIN Resources Limited reveals significant unassayed mineralised intervals at its Cabin Lake Gold Project, setting the stage for a promising 2026 drilling campaign. The discovery of a continuous 15.75m unsampled core between known high-grade zones offers a low-cost opportunity to expand the resource.

Imugene has secured FDA backing to advance its allogeneic CAR T therapy, azer-cel, into a pivotal Phase 3 trial targeting difficult-to-treat diffuse large B-cell lymphoma (DLBCL), including patients relapsed after prior CAR-T treatment.

Novatti Group’s investment in AUDC Pty Ltd, issuer of the AUDD stablecoin, has nearly doubled in value following a $5 million Pre-Series A funding round led by a major global institutional investor.

National Storage REIT has entered a definitive agreement to be acquired by a Brookfield and GIC-led consortium for $2.86 per security, valuing the company at $4 billion. The Board unanimously recommends the scheme, pending shareholder and regulatory approvals.

Chalice Mining’s Pre-Feasibility Study confirms the Gonneville Project as a globally significant palladium-nickel-copper mine in Western Australia, boasting robust returns and a rapid payback period.

Critical Resources Limited has partnered with Canada's Pathway Group to accelerate permitting, funding, and stakeholder engagement for its Mavis Lake Lithium Project, aiming to cement its role in North America's lithium supply chain.

NoviqTech has been awarded a $160,000 grant to develop Registry 2.0, a blockchain-backed platform that will modernize Eco-Markets Australia’s environmental credit system, enhancing transparency and scalability for programs like the Reef Credit Scheme.

Chimeric Therapeutics has won FDA Orphan Drug Designation for its CHM CDH17 CAR-T therapy targeting gastric cancer, advancing its clinical development with regulatory incentives and potential market exclusivity.

Telix Pharmaceuticals has dosed the first patient in the randomized expansion phase of its pivotal ProstACT Global Phase 3 trial for TLX591, targeting advanced prostate cancer. The trial is expanding globally, with regulatory submissions underway in the US and Europe.

Chalice Mining’s Pre-Feasibility Study confirms the Gonneville Project as a long-life, low-cost critical minerals mine in Western Australia, projecting A$4.7 billion pre-tax free cashflow over 23 years with rapid payback.